Please do not adjust margins
New Journal of Chemistry
Page 14 of 19
DOI: 10.1039/C5NJ03247D
ARTICLE
Journal Name
(m), 1165 (m), 1094 (m), 1069 (m), 1011 (s), 976 (m), 963 (m), 8.17 (2 H, d, J = 7.9 Hz), 8.19 (2 H, d, J = 7.9 Hz, Tolortho), 8.66 (1
H, br s, imidazole NH), 8.70 (2 H, ddd, 3J = 8.0 Hz, 4J = 1.1 Hz, 5J
793 (s), 750 (m), 725 (m), 680 (w).
3
4
= 1.0 Hz, terpyridine 3, 3’’ H), 8.77 (2 H, ddd, J = 4.8 Hz, J =
1.8 Hz, 5J = 0.9 Hz, terpyridine 6, 6’’ H), 8.79 (2 H, s, terpyridine
3’, 5’ H), 8.82 (2 H, s, Hβ), 8.93 and 8.97 (2 H, AB system, J = 4.8
Hz, Hβ), 8.93 and 8.98 (2 H, AB system, J = 4.8 Hz, Hβ) ppm.
HRMS (ESI+): m/z calcd for (C70H52N9)+: 1018.43402; found:
1018.43379 [M+H]+. λmax(CHCl3)/nm (log ε) 422 (5.12), 518
(3.95), 552 (3.64), 588 (3.57), 648 (3.27). IR: νmax/cm-1 3444 (w,
NH), 3330 (w, NH), 2954 (w), 2922 (m), 2852 (m), 1717 (m),
1604 (m), 1584 (m), 1568 (m), 1467 (m), 1390 (m), 1268 (m),
1246 (m), 1214 (m), 1181 (m), 1115 (m), 1038 (m), 1019 (m),
979 (m), 966 (m), 853(m), 791 (s), 752 (s), 732 (s), 667 (m), 660
(m).
2-(4-Carboxyphenyl)-1H-imidazo[4,5-b]-5,10,15,20-tetrakis(4-
diethoxyphosphorylphenyl)porphyrin (2H-16e) was obtained
from
2,3-dioxo-5,10,15,20-tetrakis(4-diethoxyphosphoryl-
2H-6e (34 mg, 0.029 mmol) and 4-
phenyl)chlorin
(
)
carboxybenzaldehyde (10) in 50% (19 mg) yield.
δH(300 MHz; CDCl3; 25 °C) -2.97 (2 H, br s, internal NH), 1.46–
1.56 (24 H, m, CH3), 4.30–4.46 (16 H, m, CH2), 7.66 (2 H, d, J =
7.7 Hz, HO2C-Ph), 8.04 (2 H, d, J = 7.7 Hz, HO2C-Ph), 8.22 (6 H,
dd, JPH = 12.9 Hz, J = 7.8 Hz, (EtO)2OP-Phmeta), 8.27–8.43 (10 H,
m, 2H (EtO)2OP-Phmeta and 8H (EtO)2OP-Phortho), 8.73 (2 H, s,
12,13-Hβ), 8.92 (4 H, br s, 7,8,17,18-Hβ) ppm. δP(121 MHz;
CDCl3; 25 °C) 17.95 (1 P), 18.73 (2 P), 19.62 (1 P) ppm. HRMS
(ESI+): m/z calcd for (C68H71N6O14P4)+: 1319.39732; found: Imidazo[4,5-b]porphyrin 2H-18b was obtained from 2,3-
1319.39772 [M+H]+; m/z calcd for (C68H70N6NaO14P4)+: dioxo-5,10,15,20-tetramesitylchlorin
(2H-6b) (81 mg, 0.1
1341.37927; found: 1341.37905 [M+Na]+. λmax(CHCl3)/nm (log mmol) and 4’-(4-formylphenyl)-2,2’:6’,2’’-terpyridine (12) in
ε) 421 (5.35), 517 (4.20), 549 (3.82), 587 (3.82), 645 (3.41). IR: 48% (54 mg) yield.
νmax/cm-1 3418 (w, NH), 3323 (w, NH), 2956 (m), 2924 (m), δH(300 MHz; CDCl3; 25 °C) -2.66 (2 H, br s, internal NH), 1.85-
2852 (m), 1716 (m), 1699 (m, C=O), 1601 (m), 1456 (m), 1393 1.91 (24 H, m, CH3ortho), 2.63 (6 H, s, CH3para), 2.73 (3 H, s,
(m), 1246 (m, P=O), 1165 (m, P–O), 1129 (m), 1100 (m), 1049 CH3para), 2.82 (3 H, s, CH3para), 7.28 (4 H, br s, Mes), 7.37 (2H, br
4
(s), 1018 (s), 991 (s, P–O), 794 (m), 759 (m), 730 (m), 667 (w).
s, Mes), 7.40 (2 H, ddd, 3J = 7.4 Hz, 3J = 4.8 Hz, J = 1.2 Hz,
terpyridine 5, 5’’ H), 7.53 (2 H, br s, Mes), 7.88 (2 H, d, J = 8.6
3
Hz, Ph), 7.92 (2 H, ddd, J = 7.5 Hz, 3J = 8.0 Hz, 4J = 1.8 Hz,
2-(4-Diethoxyphosphorylphenyl)-1H-imidazo[4,5-b]-
5,10,15,20-tetramesitylporphyrin (2H-17b) was obtained from
2,3-dioxo-5,10,15,20-tetramesitylchlorin (2H-6b) (292 mg, 0.36
mmol) and 4-diethoxyphosphorylbenzaldehyde (11) in 71%
(264 mg) yield.
terpyridine 4, 4’’ H), 8.07 (2 H, d, J = 8.6 Hz, Ph), 8.42 (1 H, br s,
imidazole NH), 8.60 (2 H, s, terpyridine 3’,5’ H), 8.72 (2 H, ddd,
3J = 8.0 Hz, 4J = 1.1 Hz, 5J = 1.0 Hz, terpyridine 3, 3’’ H), 8.75 and
8.82 (2 H, AB system, J = 4.8 Hz, Hβ), 8.79 (2 H, ddd, 3J = 4.8 Hz,
4J = 1.8 Hz, 5J = 0.9 Hz, terpyridine 6, 6’’ H), 8.80 and 8.87 (2 H,
AB system, J = 4.8 Hz, Hβ), 8.84 (2 H, s, 12,13-Hβ) ppm. HRMS
(ESI+): m/z calcd for (C78H68N9)+: 1130.55922; found:
1130.55895 [M+H]+. λmax(CHCl3)/nm (log ε) 421 (5.39), 517
(4.26), 548 (3.81), 587 (3.84), 646 (3.47). IR: νmax/cm-1 3415 (w,
NH), 3309 (w, NH), 2920 (m), 2852 (m), 1719 (m), 1604 (m),
1584 (m), 1567 (m), 1467 (m), 1443 (m), 1390 (m), 1378 (m),
1266 (m), 1247 (m), 1214 (m), 1170 (m), 1149 (m), 1115 (m),
1102 (m), 1037 (m), 1017 (m), 994 (m), 970 (m), 947 (m), 851
(m), 827 (m), 793 (s), 729 (s), 709 (m), 692 (m), 660 (m).
δH(300 MHz; CDCl3; 25 °C) -2.69 (2 H, br s, internal NH), 1.83 (6
H, s, CH3ortho), 1.85 (12 H, s, CH3ortho), 1.86 (6 H, s, CH3ortho), 2.61
(6 H, s, CH3para), 2.67 (3 H, s, CH3para), 2.75 (3 H, s, CH3para),
4.04–4.25 (4 H, m, CH2), 7.26 (4 H, br s, Mes), 7.32 (2 H, s,
Mes), 7.48 (2 H, s, Mes), 7.78 (2 H, dd, J = 8.3 Hz, JPH = 3.8 Hz,
(EtO)2OP-Phortho), 7.90 (2 H, dd, JPH = 12.7 Hz, J = 8.3 Hz,
(EtO)2OP-Phmeta), 8.36 (1 H, br s, imidazole NH), 8.57 (2 H, s,
12,13-Hβ), 8.72 and 8.78 (2 H, AB system, JAB = 4.8 Hz, 17,18-
Hβ), 8.78 and 8.84 (2 H, AB system, JAB = 4.8 Hz, 8,7-Hβ) ppm.
δP(121 MHz; CDCl3; 25 °C) 18.31 (1 P, s) ppm. HRMS (ESI+): m/z
calcd for (C67H68N6O3P)+: 1035.50850; found: 1035.50934
[M+H]+. λmax(CHCl3)/nm (log ε) 421 (5.35), 517 (4.22), 548 Imidazo[4,5-b]porphyrin 2H-19a was obtained from 2,3-dioxo-
(3.75), 587 (3.77), 647 (3.24). IR: νmax/cm-1 3418 (w, NH), 3323 5,10,15,20-tetratolylchlorin (2H-6a) (70 mg, 0.1 mmol) and 4’-
(w, NH), 2957 (m), 2925 (m), 2859 (m), 1720 (s), 1606 (w), formylbenzo-15-crown-5 (13) in 50% (49 mg) yield.
1506 (w), 1458 (m), 1408 (m), 1379 (m), 1265 (s), 1247 (s, δH(300 MHz; CDCl3; 25 °C) -2.90 (2 H, br s, internal NH), 2.70 (6
P=O), 1171 (m, P–O), 1115 (s), 1101 (s), 1019 (m), 969 (m, P– H, s, CH3), 2.73 (3 H, s, CH3), 2.80 (3 H, s, CH3), 3.77-3.88 (8 H,
O), 874 (m), 801 (m), 729 (s).
m, CH2), 3.91–3.97 (2 H, m, CH2), 4.01–4.07 (2 H, m, CH2),
4.16–4.22 (2 H, m, CH2), 4.26-4.32 (2 H, m, CH2), 6.92 (1 H, d, J
= 8.2 Hz, Ph), 7.09 (1 H, dd, 3J = 8.2, 4J = 2.0 Hz, Ph), 7.54 (1 H,
d, 4J = 2.0 Hz, Ph), 7.55 (4 H, d, J = 7.9 Hz, Tolmeta), 7.62 (2 H, d,
J = 8.0 Hz, Tolmeta), 7.72 (2 H, d, J = 8.0 Hz, Tolmeta), 8.11 (4 H, d,
J = 7.9 Hz, Tolortho), 8.15 (2 H, d, J = 8.0 Hz, Tolortho), 8.19 (2 H, d,
J = 8.0 Hz, Tolortho), 8.53 (1 H, br s, imidazole NH), 8.81 (2 H, s,
12,13-Hβ), 8.91 and 8.96 (2 H, AB system, J = 4.9 Hz, Hβ), 8.94
and 9.00 (2 H, AB system, JAB = 4.9 Hz, Hβ) ppm. HRMS (ESI+):
m/z calcd for (C63H57N6O5)+: 977.43850; found: 977.43951
[M+H]+; m/z calcd for (C63H56N6NaO5)+: 999.42044; found:
999.41570 [M+Na]+. λmax(CHCl3)/nm (log ε) 420 (5.44), 518
Imidazo[4,5-b]porphyrin (2H-18a) was obtained from 2,3-
dioxo-5,10,15,20-tetratolylchlorin (2H-6a) (70 mg, 0.1 mmol)
and 4’-(4-formylphenyl)-2,2’:6’,2’’-terpyridine (12) in 49% (50
mg) yield.
δH(300 MHz; CDCl3; 25 °C) -2.91 (2 H, br s, internal NH), 2.70 (6
H, s, CH3), 2.80 (3 H, s, CH3), 2.87 (3 H, s, CH3), 7.38 (2 H, ddd, 3J
= 7.6 Hz, 3J = 4.8 Hz, 4J = 1.2 Hz, terpyridine 5, 5’’ H), 7.55 (4 H,
d, J = 7.9 Hz, Tolmeta), 7.65 (2 H, d, J = 7.9 Hz, Tolmeta), 7.77 (2 H,
d, J = 7.9 Hz, Tolmeta), 7.87 (2 H, d, J = 8.6 Hz, Ph), 7.90 (2 H,
3
3
4
ddd, J = 7.9 Hz, J = 7.6 Hz, J = 1.8 Hz, terpyridine 4, 4’’ H),
8.05 (2 H, d, J = 8.6 Hz, Ph), 8.10 (4 H, d, J = 7.9 Hz, Tolortho),
14 | New J. Chem., 2016, 00, 1-3
This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins